Skip links

Virgo Welcomes Lisa La Luna to its Board of Directors



Virgo announces appointment of experienced clinical trials executive, Lisa La Luna, to its board of directors.

Lisa La Luna headshot - expert in patient recruitment

Virgo Surgical Video Solutions (Virgo), a leading provider of AI-powered solutions for endoscopy, today announced the appointment of Lisa La Luna to its board of directors.

Ms. La Luna brings over 35 years of experience in the clinical research industry to Virgo, with a particular focus on patient recruitment solutions. She has a deep understanding of the challenges and opportunities facing the healthcare industry and a proven track record of success in developing and launching innovative solutions for clinical trial sponsors.

In her previous roles, Ms. La Luna has held senior positions at leading pharmaceutical and clinical research organizations, including Boehringer Ingelheim, Genentech, MedImmune, PULSE, Acurian, ePharmaSolutions, and WCG. She has been a driving force behind the development of new technologies and services that have helped to streamline the clinical research process and accelerate the development of new therapies.

Ms. La Luna is a strong advocate for the use of technology to improve clinical trial efficiency and diversity. She is a frequent speaker at industry events and has served on numerous boards and committees, including the CNS Summit, Patients as Partners, Disruptive Clinical Trials, Young Women Rise, the Michael J. Fox Foundation, and numerous international professional and honor societies.

“We are thrilled to welcome Lisa to our board of directors,” said Matt Schwartz, CEO of Virgo. “Her extensive experience in clinical trials, her deep understanding of the challenges and opportunities facing pharmaceutical companies, and her commitment to innovation in patient recruitment will be invaluable to Virgo as we continue to grow and expand our reach. More than anything, we appreciate Ms. La Luna’s emphasis on ensuring the patient experience is at the center of new healthcare developments.”

“I am honored to join the board of directors of Virgo,” said Ms. La Luna. “I am impressed by the company’s commitment to using AI to revolutionize clinical workflows and expedite patient recruitment for clinical trials. I look forward to working with the Virgo team to help the company achieve its mission of making clinical trials more efficient, diverse, and successful.”

Virgo Partnerships

Please provide your email below to access the PDF.

Virgo Cloud

Please provide your email below to access the PDF.

Virgo Trials

Please provide your email below to access the PDF.